Skip to Content

Tranexamic acid Pregnancy and Breastfeeding Warnings

Tranexamic acid is also known as: Cyklokapron, Lysteda

Medically reviewed on Feb 21, 2017

Tranexamic acid Pregnancy Warnings

Animal studies have not shown evidence of an increased occurrence of fetal damage. There are no controlled data in human pregnancy however tranexamic acid is known to cross the placenta and appears in cord blood at concentrations approximately equal to maternal concentration.

FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

FDA pregnancy category: B

-Cyklokapron(R) is only recommended for use during pregnancy when benefit outweighs risk.
-Lysteda(R) is not indicated for use in pregnant women.

See references

Tranexamic acid Breastfeeding Warnings

Tranexamic acid should be used during lactation only if clearly needed.

Excreted into human milk: Yes
Excreted into animal milk: Data not available

The effects in the nursing infant are unknown.

Tranexamic acid is excreted into human milk at a concentration of about one hundredth of the corresponding serum concentrations.

See references

References for pregnancy information

  1. "Product Information. LYSTEDA (tranexamic acid)." Xanodyne Pharmaceuticals Inc, Newport, KY.
  2. "Product Information. Cyklokapron (tranexamic acid)." Pharmacia and Upjohn, Kalamazoo, MI.

References for breastfeeding information

  1. "Product Information. LYSTEDA (tranexamic acid)." Xanodyne Pharmaceuticals Inc, Newport, KY.
  2. "Product Information. Cyklokapron (tranexamic acid)." Pharmacia and Upjohn, Kalamazoo, MI.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide